We can highlight the next thriving fund investment areas, such as Medical, Cloud Data Services. Among the various public portfolio startups of the fund, we may underline Rimag Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Neovision Capital, Huayu Rongchuang, Huaxin Century Investment Group. In the next rounds fund is usually obtained by PICC Asset Management, CICC.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.
Related Funds
| Fund Name | Location |
| Angel Capital Management | Italy, Lombardy, Milan |
| Assiya Capital Partners | England, London, United Kingdom |
| Atlassian | Australia, New South Wales, Sydney |
| Diweideng Touzi | China, Fujian, Jimei |
| Evoco | Switzerland, Zürich, Zurich |
| Gelita AG | Baden-Württemberg, Baden-Wurttemberg, Germany |
| Genies | California, United States, Venice |
| Hangzhou Changjiang Chuang Tou | China, Hangzhou, Zhejiang |
| Invest Northern Ireland | Belfast, Northern Ireland, United Kingdom |
| LeFrak | New York, New York, United States |
| LivWell Ventures | Austin, Texas, United States |
| Maruho | - |
| RenewableTech Ventures | Salt Lake City, United States, Utah |
| Shanghai Huashi | China, Chongming, Chongming District |
| Signature Capital | County Dublin, Dublin, Ireland |
| Social Alpha | Bangalore, India, Karnataka |
| Swing for the Fence, LLC | - |
| TGV Partners | - |
| Yung's Enterprise | China, Hong Kong, Hong Kong Island |
| Zhaorun Touzi | China, Jiangsu, Suzhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ceram Pharmaceuticals | $30M | 04 Jan 2022 | Shenzhen, Guangdong, China | ||
Skynor Medical | 20 Jan 2021 | Shanghai, Shanghai, China | |||
| $64M | 01 Feb 2018 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ceram Pharmaceuticals | $30M | 04 Jan 2022 | Shenzhen, Guangdong, China | ||
Skynor Medical | 20 Jan 2021 | Shanghai, Shanghai, China | |||
| $64M | 01 Feb 2018 | China, Beijing |
